Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)
Condition: Keratoconus, Unstable Intervention: Drug: Riboflavin Sponsor: Kent Wellish MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2021 Category: Research Source Type: clinical trials
Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Conditions: Keratoconus; Pellucid Marginal Corneal Degeneration; Corneal Degeneration; Corneal Ectasia Intervention: Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution Sponsor: Cornea Associates of Texas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2020 Category: Research Source Type: clinical trials